A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an experimental compound called K884 can boost the natural repair abilities of muscle stem cells. Current treatments can slow muscle damage, but don’t address the root problem.
Categories
Recent Posts
- Izzy Camilleri Merges High Fashion and Adaptive Clothing Design
- My late brother was my greatest teacher, in life and Duchenne
- LGMD gene therapy gets FDA orphan drug designation
- Capricor plans Deramiocel resubmission to the FDA, pursuing both cardiac and skeletal muscle indications in Duchenne
- MDA Ambassador Guest Blog: Life Lessons on My Journey with Becker Muscular Dystrophy